跳至主要内容
临床试验/NCT06612307
NCT06612307已完成不适用

Sensitivity and Specificity of Leucocytes Subpopulation Versus Platelet Indices in Prediction of Clinical Outcome for Candidates With Sepsis. A Bi-centric Clinical Trial

Minia University1 个研究点 分布在 1 个国家目标入组 422 人开始时间: 2024年9月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
422
试验地点
1
主要终点
Sensitivity of either leucocyte subpopulation, platelet indices with early clinical outcome

研究概览

简要总结

Leucocyte subpopulation and platelet indices analysis can predict clinical outcome

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult population of both sex, aged 20 or older admitted to the ICU with a diagnosis of sepsis were screened for inclusion within 48 h of presentation to the hospital. Sepsis was defined as per the Sepsis-3 definition, 6 ie, the presence of suspected or documented infection with organ dysfunction determined by an acute increase of sequential organ failure assessment (SOFA) score by 2 or more points

排除标准

  • Patient refusal.
  • History of surgery in the last 7 days from admission.
  • Immunocompromised population ( post-transplantation, steroid use > 5 mg per day, malignancy, HIV, on chemotherapy).
  • History of platelet transfusion one week before admission.
  • Bone marrow transplanted population on steroid therapy.
  • Von-Willebrand disease.
  • Myelodysplastic or proliferative patients.
  • Blood dyscarsiasis
  • Obestetric parturients.

结局指标

主要结局

Sensitivity of either leucocyte subpopulation, platelet indices with early clinical outcome

时间窗: 1 week

Post hoc analysis .... \< 50 %= poor sensitivity..... \> 50%= strong sensitivity

Specificity of either leucocyte subpopulation, platelet indices with early clinical outcome

时间窗: 1 week

Post hoc analysis .... \< 50 %= poor sensitivity..... \> 50%= strong sensitivity

Sensitivity and specificity of either leucocyte profiling , platelet indices with early clinical deterioration

时间窗: from biomarker sampling through fifth calendar day

SOFA increase 2 points or more, or development of septic shock, or mortality. leukocyte profile versus platelet indices. Early deterioration was defined as any of the above mentioned events occurring for the first time from T0 until (through) second calendar day. T0 was the biomarker sampling immediately after sepsis diagnosis. Timing of deterioration was subclassified from To to second calendar day ( any deterioration events for the first time from T0 until second calendar day after that defined as very early deterioration) or early deterioration ( from third calendar day to day-5 = any deterioration events occur for the first time only from third to the fifth calendar day inclusive after T0

次要结局

  • correlation between leucocytes at enrollment , 7 days with ICU mortality(1 week)
  • correlation between platelet indices at enrollment , 7 days with ICU mortality(one week)
  • correlation between platelet indices at enrollment , 7 days with incidence of mechanical ventilation(1 week)
  • correlation between leucocytes at enrollment , 7 days with incidence of mechanical ventilation(1week)
  • correlation between leucocytes at enrollment , 7 days with incidence of acute kidney injury(1 week)
  • correlation between platelet indices at enrollment , 7 days with incidence of acute kidney injury(1 week)
  • association between leucocytes at enrollment with ICU mortality(2 weeks ( during ICU admission))
  • association between platelet indices at enrollment with ICU mortality(2 weeks (during ICU admission))
  • association between platelet indices at enrollment with incidence of mechanical ventilation(2 weeks)
  • association between leucocytes at enrollment with incidence of mechanical ventilation(2 weeks (during ICU admission))
  • association between leucocytes at enrollment , with incidence of acute kidney injury(2 weeks (during ICU admission))
  • association between platelet indices at enrollment with incidence of acute kidney injury(2 weeks (during ICU admission ))

研究者

发起方
Minia University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mina Maher

principal investigator

Minia University

研究点 (1)

Loading locations...

相似试验